valine has been researched along with Overweight in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chen, S; Eguchi, M; Fukunaga, A; Kabe, I; Kochi, T; Miki, T; Mizoue, T; Nanri, A | 1 |
Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Santoro, T; Zoppi, A | 1 |
Abraham, I; BriƩ, H; Cholette, M; Ciesielski, G; Hermans, C; Kinsey, K; Lee, C; MacDonald, K; Pacheco, C; Reel, S; Song, M; Speaks, P; Van der Niepen, P; Vancayzeele, S; Yee, B | 1 |
1 trial(s) available for valine and Overweight
Article | Year |
---|---|
Effect of valsartan addition to amlodipine on insulin sensitivity in overweight-obese hypertensive patients.
Topics: Adult; Aged; Amlodipine; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Hypertension; Insulin; Male; Middle Aged; Obesity; Overweight; Prospective Studies; Tetrazoles; Valine; Valsartan | 2008 |
2 other study(ies) available for valine and Overweight
Article | Year |
---|---|
Associations of serum amino acids with insulin resistance among people with and without overweight or obesity: A prospective study in Japan.
Topics: Alanine; Animals; Humans; Insulin; Insulin Resistance; Isoleucine; Japan; Methionine; Obesity; Overweight; Prospective Studies; Thinness; Tyrosine; Valine | 2022 |
Patient- and physician-level determinants of blood pressure response to treatment in normal weight and overweight patients (the PREVIEW study).
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Belgium; Blood Pressure; Body Mass Index; Body Weight; Clinical Competence; Female; Guideline Adherence; Humans; Hypertension; Linear Models; Logistic Models; Male; Medication Adherence; Middle Aged; Odds Ratio; Overweight; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prospective Studies; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan | 2013 |